SNDX
Syndax Pharmaceuticals IncCompany with tickers: SNDX
CIK
1395937
CUSIP
87164F105
Shares Outstanding
88,610,027
13F Activity (30d)
155 filings
151 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2022-11-03 | — | |
| 8-K | 2022-12-05 | 2022-12-01 | |
| 8-K | 2022-12-07 | 2022-12-06 | |
| 8-K | 2022-12-14 | — | |
| 8-K | 2023-02-08 | 2023-02-02 | |
| 10-K | 2023-02-28 | 2022-12-31 | |
| 8-K | 2023-02-28 | — | |
| 8-K | 2023-03-30 | 2023-03-29 | |
| DEF 14A | 2023-04-07 | 0001-01-01 | |
| 8-K | 2023-05-08 | 2023-05-05 | |
| 10-Q | 2023-05-08 | 2023-03-31 | |
| 8-K | 2023-05-18 | 2023-05-17 | |
| 8-K | 2023-05-26 | — | |
| 8-K | 2023-07-24 | — | |
| 10-Q | 2023-08-03 | 2023-06-30 | |
| 8-K | 2023-08-03 | — | |
| 8-K | 2023-10-02 | — | |
| 10-Q | 2023-11-02 | 2023-09-30 | |
| 8-K | 2023-11-02 | — | |
| 8-K | 2023-12-12 | 2023-12-10 | |
| 8-K | 2023-12-15 | 2023-12-14 | |
| 8-K | 2023-12-20 | 2023-12-19 | |
| 10-K | 2024-02-27 | 2023-12-31 | |
| 8-K | 2024-02-27 | — | |
| 8-K | 2024-03-18 | 2024-03-15 | |
| DEF 14A | 2024-04-02 | 2024-03-27 | |
| 10-Q | 2024-05-08 | 2024-03-31 | |
| 8-K | 2024-05-08 | — | |
| 8-K | 2024-05-15 | 2024-05-14 | |
| 8-K | 2024-08-01 | — | |
| 10-Q | 2024-08-01 | 2024-06-30 | |
| 8-K | 2024-11-04 | — | |
| 8-K | 2024-11-05 | — | |
| 10-Q | 2024-11-05 | 2024-09-30 | |
| 8-K | 2024-11-12 | — | |
| 8-K | 2024-11-18 | 2024-11-15 | |
| 8-K | 2024-12-20 | — | |
| 10-K | 2025-03-03 | 2024-12-31 | |
| 8-K | 2025-03-03 | — | |
| DEF 14A | 2025-04-01 | — | |
| 8-K | 2025-05-05 | — | |
| 10-Q | 2025-05-05 | 2025-03-31 | |
| 8-K | 2025-05-16 | 2025-05-12 | |
| 8-K | 2025-06-26 | 2025-06-24 | |
| 10-Q | 2025-08-04 | 2025-06-30 | |
| 8-K | 2025-08-04 | — | |
| 8-K | 2025-10-24 | — | |
| 10-Q | 2025-11-03 | 2025-09-30 | |
| 8-K | 2025-11-03 | — | |
| 8-K | 2025-12-19 | 2025-12-18 |
Showing 51–100 of 108 filings